Clinical Trial Update: GEMINI-NSCLC: NSCLC Biomarker Study

View source ↗

Summary

A clinical trial update for GEMINI-NSCLC, a biomarker study in non-small cell lung cancer sponsored by Tempus AI, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Tempus AI | Conditions: Non-Small Cell Lung Cancer | Status: RECRUITING